Lilly to Resubmit Application For Arthritis Drug

Posted: Updated:
INDIANAPOLIS -

Indianapolis-based Eli Lilly and Co. (NYSE: LLY) and Delaware-based Incyte Corp. (Nasdaq: INCY) have announced plans to resubmit the New Drug Application for a once-daily treatment for rheumatoid arthritis. In April, the U.S. Food and Drug Administration rejected an NDA for baricitinib, saying more clinical results were needed.

Lilly says the resubmission package, which will be provided to the FDA before the end of January 2018, will include new safety and efficacy data. The companies expect the FDA to classify the application as a Class II resubmission, which means a new six-month review cycle will begin.

"We are committed to making life better for people living with RA. There is a significant unmet need for Americans suffering from this debilitating disease in spite of available therapies," said Christi Shaw, president of Lilly Bio-Medicines. "We are pleased with the opportunity to provide our resubmission package for baricitinib sooner than anticipated and look forward to continuing to work with the FDA as we seek to bring baricitinib to people with RA in the U.S."

Lilly and Incyte submitted the original NDA in January 2016. The following March, the companies published results from a Phase 3 global study in the New England Journal of Medicine, showing the drug met its primary endpoint.

In July, the Japan Ministry of Health, Labor and Welfare granted marketing approval for the drug, also known as Olumiant, based on four Phase 3 clinical trials.

  • Perspectives

    • The Power of Partnerships

      You can't go it alone in tech. All technology companies, regardless of their segment, live in an ecosystem comprised of organisms of varying complexity. More mature companies in established categories can function at the top of the food chain, consuming smaller companies through acquisition, but startups are seldom if ever in a position to gain dominance through acquisition. It’s vital for the success of a startup to be able to play well with others...

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Liberty Mutual Plans 400 New Carmel Jobs

      Boston-based Liberty Mutual Group Inc. is planning to add up to 400 Carmel jobs as part of a $14 million expansion plan. The insurance company has a global presence and currently employs 1,430 in central Indiana. The Indiana Economic Development Corp. says the new jobs, expected to be created by 2021, will pay more than the state and Hamilton County average wages. Plans call for Liberty Mutual to lease...

    • Vincennes Woman Sentenced For Tax Fraud

      U.S. District Judge Richard Young has sentenced a Vincennes woman to four years in prison on tax fraud charges. U.S. Attorney Josh Minkler's office says Deborah Richards pleaded guilty to preparing more than 350 false tax returns between 2014 and 2017. 

    • Soybean Alliance Chair Appointed to National Board

      The chairman of the Indiana Soybean Alliance Board of Directors has been named to a national board. Tom Griffiths of Kendallville is one of 19 new members appointed to the United Soybean Board by U.S. Secretary of Agriculture Sonny Perdue. 

    • Opioid Withdrawal Treatment Lands FDA Clearance

      The U.S. Food and Drug Administration has given clearance for a medical device developed in Indiana to help treat symptoms of opioid withdrawal. The device, known as the NSS-2 BRIDGE, was created by Innovative Health Solutions Inc. in Versailles.

    • FedEx Plans to Pump $170M Into Indy Hub

      FedEx Corp. (NYSE: FDX) is planning a $170 million investment in its hub at Indianapolis International Airport. In a tax abatement request introduced Monday evening to the City-County Council in Indianapolis, the company says plans call for more than two dozen additional full-time and nearly 180 part-time positions. FedEx says the installation of new package-handling equipment would also help retain some 730 full-timers and 3,200 part-timers.